Wienerberger AG (WIB)
XETRA Stock Exchange · Germany · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 16.10 |
|---|---|
| 52-week range | 15.13 – 30.12 |
| Return, 1 month / 3 months | −7.2% / −24.3% |
| Return, 1 year / 3 years | −36.2% / −32.2% |
| Trend | Below its 200-day average |
| RSI (14) | 40 |
| Volatility (1 year) | 35.1% |
| Worst drawdown (1 year) | -49.0% |
| Average daily value traded | 0.10M EUR |
| Dividend yield | 5.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Wienerberger AG is an Austrian building materials company based in Vienna. It makes clay bricks and roof tiles for residential and commercial construction, and supplies concrete pavers and ceramic and plastic pipe systems for building and infrastructure work. Its customers are builders, contractors, developers and distributors across Europe and beyond, and its products are used in new construction, renovation and water management projects.
The shares are listed on the XETRA Stock Exchange in Germany under the code WIB, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Wienerberger AG (WIB) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 16.10 on 19 October 2026.
Its price-based Market X-Ray is 28 out of 100 (a weak price profile), ranking 589 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 36.2% and over the last three months it fell 24.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 10 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -29.1% | ||
| From 52-week high | -46.2% | ||
| Momentum | 11 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -24.3% | ||
| 6-month return | -32.7% | ||
| 12-month return, skipping the last month | -31.3% | ||
| Risk (lower is better) | 36 · Weak | Volatile, with deep drawdowns. | |
| Volatility (1 year) | 35.1% | ||
| Worst drawdown (1 year) | -49.0% | ||
| Liquidity | 44 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.10M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 68 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.9% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Risk (lower is better): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +4.7% |
|---|---|
| 1 month | −7.2% |
| 3 months | −24.3% |
| 6 months | −32.7% |
| 1 year | −36.2% |
| 3 years | −32.2% |
| 5 years | – |
Signals
| 50-day / 200-day average | 18.08 / 22.71 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.50 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 May 2026 | EUR 0.9500 |
| 21 May 2025 | EUR 0.9500 |
| 10 May 2024 | EUR 0.9000 |
| 9 May 2023 | EUR 0.9000 |
| 5 May 2022 | EUR 0.7500 |
| 6 May 2021 | EUR 0.6000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.